The Covid-19 pandemic has sparked an increased interest in innovation and the adoption of new technologies such as artificial intelligence (AI) and machine learning (ML) in the healthcare industry. GlobalData forecasts that the market for AI platforms for the entire healthcare industry will reach $4.3bn by 2024, up from $1.5bn in 2019. This will be driven by the use of AI by healthcare providers and payers, which is forecast to reach $2.9bn by 2024. There are a lot of areas in healthcare where AI can be applied—data management, remote surgery, diagnostic and procedural AI assistants, drug discovery, and clinical trial design—to improve the current workflow.
